S

Supernus Pharmaceuticals
D

SUPN

33.600
USD
0.74
(2.25%)
مغلق
حجم التداول
0
الربح لكل سهم
1
العائد الربحي
-
P/E
30
حجم السوق
1,881,251,333
أصول ذات صلة
ALGN
ALGN
3.420
(1.69%)
205.680 USD
A
ALKS
-0.410
(-1.55%)
26.120 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
BIIB
BIIB
-1.010
(-0.76%)
131.630 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
TEVA
TEVA
0.195
(1.19%)
16.545 USD
VRTX
VRTX
-2.89
(-0.61%)
469.58 USD
المزيد
الأخبار المقالات

العنوان: Supernus Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.